| scholarly article | Q13442814 |
| P2093 | author name string | Hanna Mawad | |
| Hartmut H Malluche | |||
| Marie-Claude Monier-Faugere | |||
| David Pienkowski | |||
| Daniel S Porter | |||
| P2860 | cites work | Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis | Q69684517 |
| A program package for quantitative analysis of histologic structure and remodeling dynamics of bone | Q70201707 | ||
| Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance in iliac bone | Q71638383 | ||
| The role of bone biopsy in the management of patients with renal osteodystrophy | Q72016390 | ||
| Risk factors for hip fracture among patients with end-stage renal disease | Q73108274 | ||
| Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone | Q73235636 | ||
| Elastic properties of human cortical and trabecular lamellar bone measured by nanoindentation | Q73860814 | ||
| Increased risk of hip fracture among patients with end-stage renal disease | Q73969374 | ||
| Risk factors for vertebral fractures in renal osteodystrophy | Q74451547 | ||
| Mechanical and morphological variation of the human lumbar vertebral cortical and trabecular bone | Q77975436 | ||
| Relationship between moderate to severe kidney disease and hip fracture in the United States | Q79150009 | ||
| Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee | Q29616160 | ||
| Value of the new bone classification system in pediatric renal osteodystrophy | Q34281410 | ||
| The importance of bone health in end-stage renal disease: out of the frying pan, into the fire? | Q34547601 | ||
| Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. | Q34590956 | ||
| Mineral changes in osteoporosis: a review | Q34600560 | ||
| Performance of μMRI-Based virtual bone biopsy for structural and mechanical analysis at the distal tibia at 7T field strength | Q34690461 | ||
| Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients | Q35854025 | ||
| Bone quality: understanding what matters | Q35991871 | ||
| The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management | Q36069258 | ||
| A new semiautomatic method for quantitative static and dynamic bone histology | Q36631655 | ||
| Fourier transform infrared spectroscopy of the solution-mediated conversion of amorphous calcium phosphate to hydroxyapatite: new correlations between X-ray diffraction and infrared data | Q36821882 | ||
| FTIR microspectroscopic analysis of human iliac crest biopsies from untreated osteoporotic bone. | Q36893198 | ||
| Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. | Q38519191 | ||
| Detection and distribution of aluminium in bone | Q39524285 | ||
| Fractures and vertebral bone mineral density in patients with renal osteodystrophy | Q41776605 | ||
| A modification of the masson trichrome technique for routine laboratory purposes. | Q42396498 | ||
| Infrared spectroscopy indicates altered bone turnover and remodeling activity in renal osteodystrophy | Q43143544 | ||
| Spectroscopic characterization of collagen cross-links in bone | Q43755569 | ||
| The degree of mineralization is a determinant of bone strength: a study on human calcanei. | Q44879082 | ||
| Relationship between tissue stiffness and degree of mineralization of developing trabecular bone | Q46279605 | ||
| Intratrabecular distribution of tissue stiffness and mineralization in developing trabecular bone | Q46279747 | ||
| Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy | Q46285845 | ||
| FTIR microspectroscopic analysis of normal human cortical and trabecular bone | Q46292104 | ||
| Calcitonin alters bone quality in beagle dogs | Q46292118 | ||
| Fourier transform-infrared microspectroscopy and microscopic imaging. | Q46606806 | ||
| Clinical epidemiology of long-bone fractures in patients receiving hemodialysis | Q46756317 | ||
| Effects of viscoelasticity and time‐dependent plasticity on nanoindentation measurements of human cortical bone | Q47596076 | ||
| Determination of bone's mechanical matrix properties by nanoindentation. | Q47722929 | ||
| Chemical makeup of microdamaged bone differs from undamaged bone. | Q51234819 | ||
| Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. | Q51789429 | ||
| PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. | Q53607251 | ||
| FTIR microspectroscopic analysis of human osteonal bone | Q57224802 | ||
| P433 | issue | 3 | |
| P921 | main subject | renal osteodystrophy | Q822598 |
| P304 | page(s) | 525-532 | |
| P577 | publication date | 2011-12-22 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Differences in bone quality in low- and high-turnover renal osteodystrophy | |
| P478 | volume | 23 |
| Q50871829 | A multiscale mechanobiological model of bone remodelling predicts site-specific bone loss in the femur during osteoporosis and mechanical disuse. |
| Q48195251 | Altered Bone Mechanics, Architecture and Composition in the Skeleton of TIMP-3-Deficient Mice |
| Q89551635 | Assessment of Renal Osteodystrophy via Computational Analysis of Label-free Raman Detection of Multiple Biomarkers |
| Q39254025 | Biomarkers Predicting Bone Turnover in the Setting of CKD. |
| Q36965098 | Bone Parameters and Risk of Hip and Femur Fractures in Patients on Hemodialysis |
| Q26863596 | Bone composition: relationship to bone fragility and antiosteoporotic drug effects |
| Q64885250 | Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD). |
| Q41625862 | Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. |
| Q26997002 | Can one evaluate bone disease in chronic kidney disease without a biopsy? |
| Q30873913 | Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease |
| Q39719456 | Cinacalcet: the chemical parathyroidectomy? |
| Q35661168 | Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions |
| Q36199520 | Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality |
| Q33727902 | Cortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease |
| Q36281399 | Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture |
| Q33602332 | Evaluating bone quality in patients with chronic kidney disease |
| Q36889362 | Examining the Relationships Between Bone Tissue Composition, Compositional Heterogeneity, and Fragility Fracture: A Matched Case-Controlled FTIRI Study |
| Q89338589 | Factors associated with low trabecular bone scores in patients with end-stage kidney disease |
| Q43820704 | Histomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease. |
| Q53752406 | Intrinsic material property differences in bone tissue from patients suffering low-trauma osteoporotic fractures, compared to matched non-fracturing women. |
| Q37190013 | Low-energy fractures without low T-scores characteristic of osteoporosis: a possible bone matrix disorder |
| Q30234751 | Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. |
| Q49166621 | Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes |
| Q36104700 | Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease. |
| Q92636296 | Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease |
| Q36823369 | Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease |
| Q52593648 | Raman Spectroscopic and Microscopic Analysis for Monitoring Renal Osteodystrophy Signatures. |
| Q59126536 | Rethinking Bone Disease in Kidney Disease |
| Q95411416 | Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers |
| Q89280856 | Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease |
| Q39569410 | Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates |
| Q64257622 | Study on the Prevalence of Vascular Calcification in Different Types of Arteries and Influencing Factors in Maintenance Peritoneal Dialysis Patients |
| Q33607092 | Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report |
| Q37670856 | The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. |
| Q36672678 | The kidney sodium-phosphate co-transporter alters bone quality in an age and gender specific manner. |
| Q38605457 | Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway |
| Q48197934 | Update on the role of bone biopsy in the management of patients with CKD-MBD. |
| Q39220959 | Vibrational spectroscopic techniques to assess bone quality |
| Q48058296 | We Use Too Much Vitamin D in Hemodialysis Patients |
| Q38825566 | What Animal Models Have Taught Us About the Safety and Efficacy of Bisphosphonates in Chronic Kidney Disease |
| Q38200705 | What is the role of bone biopsy in the management of adult dialysis patients? |
Search more.